ClinicalTrials.gg
Not yet recruitingNCT06409312Updated May 16, 2024

Digital Healthcare App After Total Hip Arthroplasty

An interventional study of Akina Cloud in Total Hip Replacement, sponsored by Schulthess Klinik. Not yet recruiting. Open to participants aged 18 Years to 75 Years. Per ClinicalTrials.gov, last updated 2024-05-16.

Sponsored by Schulthess Klinik · Not applicable, Interventional, and Health services research

From the registry’s dates

  • Primary completion was expected by Dec 2024, 1 year 10 months ago, but the record still lists the study as not yet recruiting.
Phase
Not applicable
Study type
Interventional
Enrollment
20
Allocation
Not applicable
Ages
18 Years to 75 Years
Sex
All
01

Study summary

This study examines the effectiveness of rehabilitation after hip replacement surgery using a specialised app called Akina Cloud. Medical professionals at the Schulthess Clinic will provide detailed information about the study. Participants must meet certain eligibility requirements. There will be time for consideration before enrolment. A demonstration of how to use the app will be provided upon agreement. Participants will be shown how to set up their profile and interact with a real therapist who will provide feedback. The initial 30-minute introduction is scheduled to take place a few days after surgery while still in hospital. Participants will be asked to complete several questionnaires. The rehabilitation process involves using the app for at least 12 weeks, at least three times a week, for 20-30 minutes per session. Direct communication with the therapist via the app is available for any queries. Follow-up questionnaires will be emailed at 6 and 12 weeks, after training, and again at 26 weeks to assess progress and feedback on the use of the app. Each session with the app lasts about 20 minutes and the questionnaire takes about 30 minutes to complete.

02

Conditions studied

  • Total Hip Replacement
03

In context

Lead sponsor

Schulthess Klinik is the lead sponsor of 53 studies on the registry; 11 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 75 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • signed by the subject
  • Unilateral initial implantation of a minimally-invasive hip endoprosthesis
  • Age between 18 and 75 years old
  • Ownership of a private laptop or desktop computer
  • Stable internet connection at home
  • Familiarity with the use of laptop or desktop computer

Exclusion criteria

Exclusion Criteria:

  • Bilateral initial implantation of a minimally-invasive hip endoprosthesis
  • Not fluent in German or English
  • Other conditions where active therapy is
  • Neurological diseases that limit the ability to walk
  • Chronic lower limb pain
  • Rheumatological diseases
  • Other inflammatory diseases
Terms in these criteria, in plain language(2)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

Contraindication

A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.

05

Study design

Phase
Not applicable
Primary purpose
Health services research
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
20 participants (estimated)

Study arms

  • Experimental
    Akina Cloud

    Device: Akina Cloud

Interventions

  • DeviceAkina Cloud

    Akina Cloud is a digital health application that supports the therapeutic training of people with musculoskeletal conditions. It provides two therapeutic training programs for patients, one for each specific indication. Patients have continuous access to these programs through Akina Cloud, allowing them to independently complete nine training sessions without supervision. A minimum of three sessions per week is recommended, but patients have the option to engage in daily sessions if preferred. These therapy programs are based on current treatment guidelines and supported by relevant scientific research. They include customizable physical exercises tailored to individual needs and difficulty levels. Patients receive audio-visual guidance during these exercise sessions to ensure proper execution. Exercise therapy has demonstrated its ability to reduce pain, improve physical function, and enhance the overall quality of life for patients suffering from back pain and hip osteoarthritis.

06

What researchers measure

Primary outcomes

  1. Number of completed training sessions and the number of repetitions per sessionweeks of training.

    Time frame: after 12 weeks

Secondary outcomes

  1. Intrinsic Motivation Inventory (IMI)

    Intrinsic motivation inventory (IMI) consists of 6 subscales, the items are rated on a Likert scale ranging from 1 ("not at all true") to ("very true") for each item. A higher score indicates stronger intrinsic motivation.

    Time frame: Baseline, 6 weeks, 12 weeks

  2. Net Promoter Score (NPS)

    The NPS is a metric used to assess customer loyalty and satisfaction by asking a single question: "How likely is it that you would recommend our company/product/service to a friend or colleague?"The scale ranges form 0 to 10. A higher score indicates stronger intrinsic motivation.

    Time frame: 6 weeks, 12 weeks

  3. Post-Study System Usability Questionnaire (PSSUQ)

    The Post-Study System Usability Questionnaire is a standardised questionnaire desigend to evaluate users' perceptions of the usability of a system of product after they have interacted with it.The questionnaire consists of a set of Likert-scale questions that cover various aspects of the user experience. The lower the score, the better the performance and satisfaction.

    Time frame: 6 weeks, 12 weeks

  4. Hip disability and Osteoarthritis Outcome Score

    The Hip disability and Osteoarthritis Outcome Score is a self-report questionnnaire with five subsets (pain, symptoms, activities of daily living, sports and recreations and quality in life). The scores range from 0 to 100, where a higehr score indicate less ssymptoms and disability.

    Time frame: 6 weeks, 12 weeks, 26 weeks

  5. International Physical Activity Questionnaire

    The questionnaire covers activities such as work-related, transportation, household chores, and leisure-time activities. The responses are then used to categorise individuals into different levels of physical activity, ranging from low to high.

    Time frame: 6 weeks, 12 weeks, 26 weeks

07

Study locations

No study locations are listed for this record.

08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on May 16, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06409312
Lead sponsor
Schulthess Klinik
Responsible party
Sponsor
First posted
May 10, 2024
Start date
May 21, 2024 (estimated)
Primary completion
Dec 31, 2024 (estimated)
Completion
May 30, 2025 (estimated)
Last update
May 16, 2024

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in May 2024. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion